Cohen & Company Appoints New Director to Expand Advisory Capabilities
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Should l Buy COHN?
Source: Newsfilter
- Increased Deal Flow: Cohen & Company Capital Markets nearly doubled its deal flow in 2025, closing $43 billion in transactions, indicating robust performance in capital markets and laying a strong foundation for future growth.
- Executive Appointment: Pawel Skonieczka has been appointed as Managing Director to lead the expansion of the firm's advisory capabilities in Space Technology, Aerospace, and Communications Infrastructure, reflecting the company's focus on high-growth industries.
- Rich Industry Experience: Skonieczka's nearly decade-long tenure at Deutsche Bank has equipped him with extensive experience in the Space Technology sector, enabling him to provide strategic transaction and capital formation advice that enhances the firm's competitive edge.
- Strategic Investment Focus: Cohen & Company's management emphasizes that the future of the space industry will be driven by consolidation, scale, and disciplined capital deployment, and Skonieczka's addition will further strengthen the firm's advisory platform in this transformation.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy COHN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on COHN
About COHN
Cohen & Company Inc. is a financial services company specializing in a range of capital markets and asset management services. The Company’s segments include Capital Markets, Asset Management, and Principal Investing. The Capital Markets business segment consists of fixed income sales, trading, and gestation repo financing, new issue placements in corporate and securitized products, underwriting, and advisory services, operating primarily through its subsidiaries, Cohen & Company Securities, LLC in the United States and Cohen & Company Financial (Europe) S.A. in Europe. The Asset Management segment manages assets through collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment comprises investments the Company holds related to its special purpose acquisition company (SPAC) franchise and other investments the Company has made for the purpose of earning an investment return.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cohen & Company Appoints New Director to Expand Advisory Capabilities
- Increased Deal Flow: Cohen & Company Capital Markets nearly doubled its deal flow in 2025, closing $43 billion in transactions, indicating robust performance in capital markets and laying a strong foundation for future growth.
- Executive Appointment: Pawel Skonieczka has been appointed as Managing Director to lead the expansion of the firm's advisory capabilities in Space Technology, Aerospace, and Communications Infrastructure, reflecting the company's focus on high-growth industries.
- Rich Industry Experience: Skonieczka's nearly decade-long tenure at Deutsche Bank has equipped him with extensive experience in the Space Technology sector, enabling him to provide strategic transaction and capital formation advice that enhances the firm's competitive edge.
- Strategic Investment Focus: Cohen & Company's management emphasizes that the future of the space industry will be driven by consolidation, scale, and disciplined capital deployment, and Skonieczka's addition will further strengthen the firm's advisory platform in this transformation.
See More
Cohen & Company Completes Final Closing of PriDe IV Fund
- Total Commitments: Cohen & Company Financial (Europe) S.A. successfully completed the final closing of its PriDe IV fund with total commitments of €481.5 million, reinforcing the company's leadership in investing in Tier II capital instruments for small and mid-sized insurance companies.
- Market Demand Response: The PriDe IV fund focuses on investing in Tier II capital instruments issued by small and mid-sized insurers, enabling these companies to enhance their regulatory capital ratios and optimize reinsurance programs, thereby strengthening their competitive position in the market.
- Investor Confidence: CEO Lester Brafman highlighted that investor confidence in the company's expertise navigating the insurance industry's regulatory capital framework was pivotal for the successful fundraising, reflecting strong demand for insurance subordinated debt in the current market.
- Partner Contributions: Alma Capital and Bury Street Capital played crucial roles in the success of PriDe IV, raising 43% and 31% of total commitments respectively, showcasing their close collaboration on high-quality investment opportunities.
See More
Columbus Circle Capital Corp. II Successfully Completes IPO
- IPO Success: Columbus Circle Capital Corp. II successfully completed its initial public offering of 23 million units, priced at $10.00 per unit, raising a total of $230 million, reflecting strong market confidence in its business model.
- Unit Structure Analysis: Each unit consists of one Class A ordinary share and one-third of a redeemable warrant, which allows holders to purchase one Class A ordinary share at $11.50, enhancing potential returns for investors.
- Market Trading Launch: The company's units began trading on the Nasdaq Global Market on February 11, 2026, marking its official entry into the capital markets and is expected to attract more investor interest.
- Transparent Fund Usage: The $230 million raised will be placed in the company's trust account to benefit public shareholders while providing funding for future business combinations or acquisitions, demonstrating the company's strategic planning for future growth.
See More
Cohen & Company Opens Houston Office, Secures $44 Billion in 2025 Transactions
- Strategic Expansion: Cohen & Company Capital Markets has opened a new office in Houston, aiming to serve as a hub for energy and energy transition advisory services, which is expected to further enhance its market share in the energy sector.
- Leadership Appointment: Rahul Jasuja has been appointed as Head of Energy and Energy Transition, bringing 20 years of investment banking experience that is anticipated to enhance the firm's advisory capabilities, particularly in M&A and capital markets transactions.
- Market Trend Insight: The firm emphasizes that energy transition is crucial for the expansion of the global energy system, with Houston serving as a center for capital and operational expertise to support the growing energy demand and promote sustainability.
- Investment in Frontier Technology: Cohen & Company Capital Markets plans to increase investments in infrastructure for the digital economy, particularly in areas like nuclear and rare earth technologies, to address the upcoming cycle of value creation.
See More
UniFirst Corp Reports Mixed Q1 Results, Shares Drop 4%
- Earnings Miss: UniFirst Corp reported adjusted earnings of $1.97 per share for Q1, falling short of market expectations of $2.06, indicating challenges in profitability that may affect investor confidence.
- Sales Slightly Exceed Expectations: The company’s quarterly sales reached $621.318 million, slightly above the expected $615.253 million, suggesting some market demand remains despite earnings concerns.
- Stock Price Reaction: Following the mixed results, UniFirst's shares dropped approximately 4% on Wednesday, reflecting market worries about the company's future profitability and potentially prompting investors to reassess their strategies.
- Industry Impact: In a mixed market where healthcare stocks rose by 1.4% and materials stocks fell by 1%, UniFirst's performance may influence its competitive position within the materials sector.
See More
Bright Minds Biosciences Launches $100 Million Public Offering
- Public Offering Impact: Bright Minds Biosciences Inc's announcement of a $100 million public offering led to a 2.3% drop in its pre-market share price to $91.03, reflecting market concerns over the new issuance and potentially impacting the company's short-term financing capabilities.
- Market Reaction: Following the public offering news, Bright Minds' stock price decline indicates cautious investor sentiment regarding the company's future prospects, which may lead to increased financing costs.
- Industry Dynamics: This offering has drawn attention within the biotech sector, particularly as investor acceptance of new issues diminishes in the current market environment, potentially affecting financing plans for other biotech firms.
- Competitive Pressure: The decline in Bright Minds' stock price coincides with fluctuations in shares of other companies like Cohen & Company and Gloo Holdings, highlighting overall market uncertainty in the biotech sector, which could undermine investor confidence across the industry.
See More
Cohen & Company Appoints New Director to Expand Advisory Capabilities
- Increased Deal Flow: Cohen & Company Capital Markets nearly doubled its deal flow in 2025, closing $43 billion in transactions, indicating robust performance in capital markets and laying a strong foundation for future growth.
- Executive Appointment: Pawel Skonieczka has been appointed as Managing Director to lead the expansion of the firm's advisory capabilities in Space Technology, Aerospace, and Communications Infrastructure, reflecting the company's focus on high-growth industries.
- Rich Industry Experience: Skonieczka's nearly decade-long tenure at Deutsche Bank has equipped him with extensive experience in the Space Technology sector, enabling him to provide strategic transaction and capital formation advice that enhances the firm's competitive edge.
- Strategic Investment Focus: Cohen & Company's management emphasizes that the future of the space industry will be driven by consolidation, scale, and disciplined capital deployment, and Skonieczka's addition will further strengthen the firm's advisory platform in this transformation.
See More
Cohen & Company Completes Final Closing of PriDe IV Fund
- Total Commitments: Cohen & Company Financial (Europe) S.A. successfully completed the final closing of its PriDe IV fund with total commitments of €481.5 million, reinforcing the company's leadership in investing in Tier II capital instruments for small and mid-sized insurance companies.
- Market Demand Response: The PriDe IV fund focuses on investing in Tier II capital instruments issued by small and mid-sized insurers, enabling these companies to enhance their regulatory capital ratios and optimize reinsurance programs, thereby strengthening their competitive position in the market.
- Investor Confidence: CEO Lester Brafman highlighted that investor confidence in the company's expertise navigating the insurance industry's regulatory capital framework was pivotal for the successful fundraising, reflecting strong demand for insurance subordinated debt in the current market.
- Partner Contributions: Alma Capital and Bury Street Capital played crucial roles in the success of PriDe IV, raising 43% and 31% of total commitments respectively, showcasing their close collaboration on high-quality investment opportunities.
See More
Columbus Circle Capital Corp. II Successfully Completes IPO
- IPO Success: Columbus Circle Capital Corp. II successfully completed its initial public offering of 23 million units, priced at $10.00 per unit, raising a total of $230 million, reflecting strong market confidence in its business model.
- Unit Structure Analysis: Each unit consists of one Class A ordinary share and one-third of a redeemable warrant, which allows holders to purchase one Class A ordinary share at $11.50, enhancing potential returns for investors.
- Market Trading Launch: The company's units began trading on the Nasdaq Global Market on February 11, 2026, marking its official entry into the capital markets and is expected to attract more investor interest.
- Transparent Fund Usage: The $230 million raised will be placed in the company's trust account to benefit public shareholders while providing funding for future business combinations or acquisitions, demonstrating the company's strategic planning for future growth.
See More
Cohen & Company Opens Houston Office, Secures $44 Billion in 2025 Transactions
- Strategic Expansion: Cohen & Company Capital Markets has opened a new office in Houston, aiming to serve as a hub for energy and energy transition advisory services, which is expected to further enhance its market share in the energy sector.
- Leadership Appointment: Rahul Jasuja has been appointed as Head of Energy and Energy Transition, bringing 20 years of investment banking experience that is anticipated to enhance the firm's advisory capabilities, particularly in M&A and capital markets transactions.
- Market Trend Insight: The firm emphasizes that energy transition is crucial for the expansion of the global energy system, with Houston serving as a center for capital and operational expertise to support the growing energy demand and promote sustainability.
- Investment in Frontier Technology: Cohen & Company Capital Markets plans to increase investments in infrastructure for the digital economy, particularly in areas like nuclear and rare earth technologies, to address the upcoming cycle of value creation.
See More
UniFirst Corp Reports Mixed Q1 Results, Shares Drop 4%
- Earnings Miss: UniFirst Corp reported adjusted earnings of $1.97 per share for Q1, falling short of market expectations of $2.06, indicating challenges in profitability that may affect investor confidence.
- Sales Slightly Exceed Expectations: The company’s quarterly sales reached $621.318 million, slightly above the expected $615.253 million, suggesting some market demand remains despite earnings concerns.
- Stock Price Reaction: Following the mixed results, UniFirst's shares dropped approximately 4% on Wednesday, reflecting market worries about the company's future profitability and potentially prompting investors to reassess their strategies.
- Industry Impact: In a mixed market where healthcare stocks rose by 1.4% and materials stocks fell by 1%, UniFirst's performance may influence its competitive position within the materials sector.
See More
Bright Minds Biosciences Launches $100 Million Public Offering
- Public Offering Impact: Bright Minds Biosciences Inc's announcement of a $100 million public offering led to a 2.3% drop in its pre-market share price to $91.03, reflecting market concerns over the new issuance and potentially impacting the company's short-term financing capabilities.
- Market Reaction: Following the public offering news, Bright Minds' stock price decline indicates cautious investor sentiment regarding the company's future prospects, which may lead to increased financing costs.
- Industry Dynamics: This offering has drawn attention within the biotech sector, particularly as investor acceptance of new issues diminishes in the current market environment, potentially affecting financing plans for other biotech firms.
- Competitive Pressure: The decline in Bright Minds' stock price coincides with fluctuations in shares of other companies like Cohen & Company and Gloo Holdings, highlighting overall market uncertainty in the biotech sector, which could undermine investor confidence across the industry.
See More
